
Promising breakthrough: Widely-used diabetes drugs reduce dementia risk by up to 43%, sparking hope for Alzheimer’s care
Originally developed to manage blood sugar in type 2 diabetes, drugs like semaglutide — sold under brand names Ozempic and Wegovy — are now showing promise in a radically different realm: brain health. Two recent studies, suggest these medications may …